APA

Wang A., Yan X., Wu H., Wang W., Hu C., Chen C., Zhao Z., Zhao P., Li X., Wang L., Wang B., Ye Z., Wang J., Wang C., Zhang W., Gray N. S., Weisberg E. L., Chen L., Liu J., Yun C. & Liu Q. (20180213). Ibrutinib targets mutant-EGFR kinase with a distinct binding conformation. : Oncotarget.

Chicago

Wang Aoli, Yan Xiao-E, Wu Hong, Wang Wenchao, Hu Chen, Chen Cheng, Zhao Zheng, Zhao Peng, Li Xixiang, Wang Li, Wang Beilei, Ye Zi, Wang Jinhua, Wang Chu, Zhang Wei, Gray Nathanael S, Weisberg Ellen L, Chen Liang, Liu Jing, Yun Cai-Hong and Liu Qingsong. 20180213. Ibrutinib targets mutant-EGFR kinase with a distinct binding conformation. : Oncotarget.

Harvard

Wang A., Yan X., Wu H., Wang W., Hu C., Chen C., Zhao Z., Zhao P., Li X., Wang L., Wang B., Ye Z., Wang J., Wang C., Zhang W., Gray N. S., Weisberg E. L., Chen L., Liu J., Yun C. and Liu Q. (20180213). Ibrutinib targets mutant-EGFR kinase with a distinct binding conformation. : Oncotarget.

MLA

Wang Aoli, Yan Xiao-E, Wu Hong, Wang Wenchao, Hu Chen, Chen Cheng, Zhao Zheng, Zhao Peng, Li Xixiang, Wang Li, Wang Beilei, Ye Zi, Wang Jinhua, Wang Chu, Zhang Wei, Gray Nathanael S, Weisberg Ellen L, Chen Liang, Liu Jing, Yun Cai-Hong and Liu Qingsong. Ibrutinib targets mutant-EGFR kinase with a distinct binding conformation. : Oncotarget. 20180213.